Methods of Treating Locally Advanced or Metastatic Breast Cancers Using PD-1 Axis Binding Antagonists and Taxanes
Summary
The European Patent Office published patent application EP3310815A1, filed by F. Hoffmann-La Roche AG, covering methods of treating locally advanced or metastatic breast cancers using PD-1 axis binding antagonists in combination with taxanes. Inventor is Daniel S. Chen. The publication includes IPC classifications covering therapeutic antibodies, antineoplastic compositions, and designated states for national phase entry.
What changed
The European Patent Office published patent application EP3310815A1 for methods of treating locally advanced or metastatic breast cancers using PD-1 axis binding antagonists combined with taxanes, filed by F. Hoffmann-La Roche AG with inventor Daniel S. Chen. The application covers therapeutic uses of PD-1/PD-L1 inhibitors with taxane chemotherapy.
Competitors developing breast cancer treatments involving PD-1 pathway inhibitors should review the scope of these patent claims for freedom-to-operate considerations or potential design-around opportunities.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC BREAST CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES
Publication EP3310815A1 Kind: A1 Apr 08, 2026
Applicants
F. Hoffmann-La Roche AG
Inventors
CHEN, Daniel, S.
IPC Classifications
C07K 16/28 20060101AFI20251110BHEP A61K 31/337 20060101ALI20251110BHEP A61P 35/04 20060101ALI20251110BHEP A61K 39/00 20060101ALI20251110BHEP A61K 31/519 20060101ALI20251110BHEP A61P 35/00 20060101ALI20251110BHEP A61P 37/02 20060101ALI20251110BHEP A61P 37/04 20060101ALI20251110BHEP A61P 43/00 20060101ALI20251110BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.